H

Hemoshear

60 employees

HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Drug Discovery & Development
Rare Metabolic Diseases
Human Disease Research
Medical
NASH

Date founded

2008

Funding rounds raised

Total raised

$40M

from 2 investors over 2 rounds

H

Hemoshear raised $40M on February 10, 2021

Investors: Adage Capital Management and Suvretta Capital Management LLC

FAQ